Sign in
CompletedNo phase

Prospective Study for Aortic Arch Therapy With stENt-graft for Chimney technologY(PATENCY)

Key facts

Who runs it
Lifetech Scientific (Shenzhen) Co., Ltd.
Where
China21 sites in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
150 people enrolled
Started
1 Feb 2019
Ended
1 Jun 2025
Type of study
Interventional
Treatments tested
  • Artery Stent Graft System
Record updated
18 June 2025

Who can take part

Age
18 years to 85 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 27 criteriaShow less

Who can take part

  • Patients are 18 years and older, but less than 85 years old and not pregnant or lactating
  • Patients who can understand the purpose of the trial, voluntarily participate in and sign the informed consent, and are willing to complete the follow-up according to the requirements of the protocol
  • Patients diagnosed as thoracic aortic dissection involving the arch, and the left subclavian artery branching vessel needs to be revascularized
  • Aortic proximal landing zone ≥15mm;
  • Aortic proximal diameter in the range of 25-44mm
  • The left subclavian artery distal landing zone≥15mm
  • The left subclavian artery diameter in the range of 5-18mm;
  • Patients who have eligible imported arterial vessels

Who cannot take part

  • Patients have received any major surgical or interventional therapy within 30 days (Operation Classification reaches III or above) or have received interventional therapy
  • Patients will receive any major selective operation or interventional therapy in 30days (Operation Classification reaches III or above) or will received interventional therapy
  • Patients already treated with an thoracic aortic stent graft and the stent graft can affect operation or intersection part existing between the graft covering area;
  • Patients who participated in clinical trials of other drugs or medical devices at the same time
  • Patients need intervention for other vascular diseases (such as coronary artery /renal artery) in the same surgery, or patients with heart disease and medicine treatment will be affected by the intervention;
  • Patients with a history of myocardial infraction or acute coronary syndromes in 3 months;
  • Patients with a history of cerebrovascular events or gastrointestinal bleeding in 3 months, antiplatelet agent and anticoagulant contraindication, or tendency of hemorrhage;
  • Patients with genetic connective tissue disease (e.g., Marfans syndrome) or aorta hereditary disease;
  • Patients with acute systemic infection
  • Patients with major organ failure or other serious diseases
  • Patients with a history of active bleeding, clotting disorder, or rejection of blood transfusions
  • Patients with a history of allergy to contrast media, stents and conveyor materials (including nickel and titanium, polyester, PTFE, and nylon polymer materials)
  • Patients with a life expectancy less than 12 months(such as terminal malignant tumor);
  • Patients with liver dysfunction: preoperative creatinine was 2.5 times higher than the normal upper limit; Alanine transaminase (ALT) or Aspartate transaminase (AST) were 5 times higher than the normal upper limit; serum total bilirubin (STB) was 2 times higher than the normal upper limit
  • Patients with severe stenosis, calcification in the landing area of the stent and easily lead to incomplete stent apposition
  • Patients with infectious aortic dissection
  • Pregnant or lactating women or women who plan to get pregnant
  • Patients who can not tolerate to Anaesthetic;
  • Patients who were not suitable for endovascular treatment, judged by the investigator

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

A prospective, multi-centre, objective performance criteria clinical trial to evaluate the safety and efficacy of Artery Stent Graft System manufactured by Lifetech Scientific (Shenzhen) Co., LTD. for the thoracic aortic dissection involving the aortic arch.

The group in the trial

  • Intervention armTreatment being tested

    Participants will be treated with Artery Stent Graft System Intervention: Device: Artery Stent Graft System

    Treatment: Artery Stent Graft System

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Prospective Study for Aortic Arch Therapy With stENt-graft for Chimney technologY:A Prospective, Multi-center, Objective Performance Criteria Clinical Trial
Publications
Record updated
18 June 2025